First-ever in-utero stem cell therapy for fetal spina bifida repair shows safe results
Medical Xpress
February 26, 2026
A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida. This is the first time live stem cells have been used on a fetus's damaged spine, which could potentially lead to better health outcomes for babies compared to traditional fetal surgery.
Verticals
healthmedical
Originally published on Medical Xpress on 2/26/2026